Lim, Soo Kun
Goh, Bak Leong
Visvanathan, Ravindran
Kim, Su Hyun
Jeon, Jin Seok
Kim, Sung Gyun
Chang, Jae Hyun
Lim, Chun Soo
Morad, Zaki
Article History
Received: 22 May 2021
Accepted: 3 November 2021
First Online: 25 November 2021
Change Date: 3 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12882-021-02651-0
Declarations
:
: The study has obtained approval from National Medical Research Register Medical Research and Ethics Committee (NMRR-13-400-16313) prior to study initiation. All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all study subjects before being enrolled into the study.
: Not Applicable.
: Zaki Morad was appointed to the Board of Directors at Duopharma Biotech Bhd. (Malaysia) in September 2019, after the completion of the study. All other authors had no conflict of interest to disclose.